UNSPSC 85543229: Restriction of right neck lymphatic with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of right neck lymphatic with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07V14DZ

UNSPSC 85543229 Restriction of right neck lymphatic with intraluminal device, percutaneous endoscopic approach is a Commodity code that shows no recent activity aligned with its medical-procedural scope. The recent opportunities tagged under this code in state and local procurement—independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, surgical benefit carve-outs, youth detention healthcare, and temporary health professional staffing—represent broad administrative and clinical workforce sourcing, not the specific lymphatic procedural intervention the code names. The mismatch suggests either catalog misclassification or use of an overly broad proxy code by issuing bodies; the code does not reflect what state and local governments are actually buying in this taxonomy tier.

The geographic spread of the loosely-tagged opportunities spans Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington (WSDOT), Texas (Harris County), and Florida (Collier County), but no pattern of repeat activity under this code supports a portfolio analysis. Representatives of the recent solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance (RFP20260825, due October 9, 2026), and the County of Santa Clara Health System's RFQ for temporary health professional staffing services (RFSQHHSFY270052, due October 7, 2026). Unless your firm has a clinical or procedural offering narrowly aligned to the code's stated scope—percutaneous endoscopic restriction of right neck lymphatic pathways—this code presents no actionable state and local procurement opportunity and warrants skip status.